Listen
LIPIODOL ULTRA-FLUIDE (iodine), iodinated contrast medium
RADIOLOGY - New indication
Opinions on drugs -
Posted on
Feb 21 2017
Reason for request
Extension of indication
- LIPIODOL ULTRA-FLUIDE now has Marketing Authorisation in transarterial chemoembolisation of intermediate stage hepatocellular carcinoma in adults.
- This is an established use for which LIPIODOL ULTRA-FLUIDE represents a minor improvement in terms of efficacy when compared with supportive care or systemic chemotherapy.
- In this indication, no clinical benefit was demonstrated when compared with microspheres carrying cytotoxic agents.
Clinical Benefit
| Substantial |
- |
Clinical Added Value
| minor |
- |
Therapeutic use
|
- |
English version
Contact Us
Évaluation des médicaments
